Dr.Reddy’s  Lab is down over 1.5% at Rs.2078.50 and it had hit an intra day low at Rs.2062, this is a sharp fall from the opening at Rs.2110.

The stock is down on news that the company has had to recall total of five lots of Ranitidine Hydrochloride tablets, USP, used in gastric problems, and 150 mg bottles from the US market due to microbial contamination of non-sterile products.